Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

Medicare beneficiaries who take a lot of pricey medications will get a big break in 2025. That’s when the $2,000 annual cap on out-of-pocket costs for drugs bought at the pharmacy or through ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

The company raised costs by about 15% on its Hodgkin’s disease treatment Matulane and about 20% on Cystaran eye drops. The cost of list prices ... prices for new drugs, the assessment revealed ...